HRSA Funding Opportunities: Rapid ART, Clinical Consultation, Data, and TargetHIV
Content From: TargetHIV•Published: November 19, 2019•2 min read
Cross-posted from TargetHIVExit Disclaimer
HRSA released four Notices of Funding Opportunity (NOFO), each with the ultimate goal of supporting the Ryan White HIV/AIDS Program (RWHAP) HIV care system. They include:
- Rapid Antiretroviral Therapy (ART) Start in the Ryan White HIV/AIDS Program – Dissemination Assistance Provider (HRSA-20-076), a three-year SPNS initiative "to fund a single organization that will develop a compendium of promising rapid ART interventions." A pre-application webinar will be held December 17, 2020Exit Disclaimer. Applications are due March 3, 2020.
- AIDS Education and Training Center National Clinician Consultation Center (HRSA-20-072), "to provide immediate expert consultation to health care professionals on HIV prevention, care, and treatment including diagnosis, testing, antiretroviral therapy, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), perinatal HIV management, hepatitis B and C virus HIV coinfections, and behavioral health management for people with HIV." A pre-webinar is scheduled for December 9, 2020Exit Disclaimer. Applications are due January 13, 2020.
- Data Integration, Systems, and Quality (DISQ) Technical Assistance (HRSA-20-070), "to provide onsite and virtual technical assistance to RWHAP recipients and subrecipients to increase data-related capacity and improve the ease, completeness, timeliness, and accuracy of program data." Applications are due January 22, 2020.
- TargetHIV (HRSA-20-094), "to serve RWHAP recipients, subrecipients, and HIV providers by providing readily accessible, up-to-date T/TA tools and resources through a web-based platform." A pre-application webinar to discuss HRSA-20-070 and HRSA-20-094 is scheduled for December 9, 2020Exit Disclaimer. Applications are due January 22, 2020.